Get the Stockscreener App
5.72
1.42%
0.08
After Hours:
5.72
Seres Therapeutics Inc Stock (MCRB) Forecast
The Seres Therapeutics Inc (MCRB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.96, representing a +109.11% increase from the current price of $5.72. The highest analyst price target is $19.54, and the lowest is $4.3794.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MCRB Price Target
Average 10.28
(+79.74% Upside)
Is Seres Therapeutics Inc (MCRB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.40 | Neutral |
| STOCH(9,6) | 86.78 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.066 | Buy |
| ADX(14) | 26.90 | Buy |
| William %R | -14.07 | Sell |
| CCI(14) | 149.02 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.147
Buy
|
5.2358
Buy
|
| MA20 |
4.8755
Buy
|
5.093
Buy
|
| MA50 |
5.4689
Buy
|
5.4744
Buy
|
| MA100 |
6.4384
Sell
|
6.6079
Sell
|
| MA200 |
9.7539
Sell
|
8.492
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, MCRB could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 7 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on MCRB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.4 indicates that MCRB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 86.78 indicates that MCRB is oversold. This means that MCRB price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MCRB is oversold. This suggests that MCRB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.9 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 149.02 indicates that MCRB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term MCRB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Seres Therapeutics Inc financial reports and earnings history, Seres Therapeutics Inc (MCRB) stock could reach $3.5643 by 2030, $2.6823 by 2040 and $2.221 by 2050. See the projected annual prices until 2050 of the Seres Therapeutics Inc stock below:
- Seres Therapeutics Inc (MCRB) is expected to reach an average price of $1.0072 in 2035, with a high prediction of $0.8635 and a low estimate of $0.9597. This indicates an $-82.39% rise from the last recorded price of $5.72.
- Seres Therapeutics Inc (MCRB) stock is projected to chart a bullish course in 2040, with an average price target of $0.7145, representing an $-87.51% surge from its current level. The forecast ranges from a conservative $0.7095 to a sky-high $2.6823.
- Our analysts predict Seres Therapeutics Inc (MCRB) to jump -96.75% by 2045, soaring from $0.4227 to an average price of $0.1861, potentially reaching $0.5473. While $0.4227 is the low estimate, the potential upside is significant.
- Seres Therapeutics Inc (MCRB) stock is expected to climb by 2050, reaching an average of $2.3957, a $-58.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.221 and $2.1367, respectively, highlighting the market's uncertainty.
Seres Therapeutics Inc Stock (MCRB) Year by Year Forecast
Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2026
The predicted value for Seres Therapeutics Inc (MCRB) in 2026 is set at an average of $19.48. Estimates vary from a peak of $35.82 to a trough of $3.1529, indicating an +240.64% surge from the present price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $4.6594 | $4.3794 | $19.54 | -18.54% |
| November, 2026 | $4.1257 | $3.5566 | $4.7085 | -27.87% |
| December, 2026 | $4.721 | $3.1529 | $5.011 | -17.46% |
Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Seres Therapeutics Inc (MCRB) is $5.1008, with a high forecast of $9.5507 and a low forecast of $0.6508. This indicates an -10.83% decrease from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.0573 | $3.7673 | $5.0792 | -29.07% |
| February, 2027 | $6.9935 | $3.7654 | $7.0481 | +22.26% |
| March, 2027 | $6.1889 | $5.7489 | $9.5507 | +8.20% |
| April, 2027 | $5.9551 | $5.4351 | $7.1678 | +4.11% |
| May, 2027 | $5.3314 | $4.7133 | $6.4174 | -6.79% |
| June, 2027 | $4.2967 | $4.2217 | $6.6195 | -24.88% |
| July, 2027 | $5.153 | $4.2658 | $5.8949 | -9.91% |
| August, 2027 | $3.3093 | $3.2493 | $5.7211 | -42.15% |
| September, 2027 | $1.3046 | $1.0196 | $3.4983 | -77.19% |
| October, 2027 | $1.0108 | $0.6508 | $2.4313 | -82.33% |
| November, 2027 | $2.2371 | $1.1299 | $2.2971 | -60.89% |
| December, 2027 | $3.6024 | $1.5752 | $3.6124 | -37.02% |
Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2028
In 2028, Seres Therapeutics Inc (MCRB) is projected to reach an average price of $5.4908, with a high projection of $7.8493 and a low estimate of $3.1322. This indicates an -4.01% fall from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.6587 | $3.1837 | $4.1906 | -36.04% |
| February, 2028 | $4.725 | $3.6278 | $5.6868 | -17.40% |
| March, 2028 | $7.2103 | $4.0062 | $7.4603 | +26.05% |
| April, 2028 | $5.5365 | $4.6465 | $7.8493 | -3.21% |
| May, 2028 | $3.6719 | $3.6319 | $5.6956 | -35.81% |
| June, 2028 | $3.6781 | $3.2159 | $4.25 | -35.70% |
| July, 2028 | $3.9244 | $3.6472 | $4.2053 | -31.39% |
| August, 2028 | $3.8097 | $3.3816 | $4.7197 | -33.40% |
| September, 2028 | $4.356 | $3.7688 | $4.9277 | -23.85% |
| October, 2028 | $4.5322 | $3.1322 | $5.4741 | -20.77% |
| November, 2028 | $3.5376 | $3.2294 | $4.7113 | -38.15% |
| December, 2028 | $3.4938 | $3.3038 | $4.9457 | -38.92% |
Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2029
The 2029 price forecast for Seres Therapeutics Inc Stock (MCRB) is $2.0298 on average, with a high prediction of $4.0482 and a low estimate of $0.0114. This represents an -64.51% decrease from the previous price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.5592 | $3.0301 | $3.7429 | -37.78% |
| February, 2029 | $2.3154 | $2.0314 | $4.0482 | -59.52% |
| March, 2029 | $1.6817 | $1.6317 | $2.4826 | -70.60% |
| April, 2029 | $0.3579 | $0.1779 | $1.6757 | -93.74% |
| May, 2029 | $0.0817 | $0.142 | $0.5242 | -98.57% |
| June, 2029 | $0.00953 | $0.0595 | $0.3523 | -99.83% |
| July, 2029 | $0.3758 | $0.0114 | $0.5058 | -93.43% |
| August, 2029 | $0.1511 | $0.0621 | $1.0439 | -97.36% |
| September, 2029 | $0.1174 | $0.0492 | $0.2283 | -97.95% |
| October, 2029 | $0.1285 | $0.051 | $0.3196 | -97.75% |
| November, 2029 | $0.3011 | $0.1364 | $0.2011 | -94.74% |
| December, 2029 | $2.41 | $0.0129 | $1.89 | -57.87% |
Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2030
Seres Therapeutics Inc Stock (MCRB) is expected to reach an average price of $3.2333 in 2030, with a high forecast of $4.1212 and a low forecast of $2.3454. This signifies an -43.47% decrease from the last price of $5.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6693 | $2.9019 | $3.5643 | -18.37% |
| February, 2030 | $3.9118 | $3.955 | $4.1212 | -31.61% |
| March, 2030 | $4.3593 | $4.0286 | $3.9543 | -23.79% |
| April, 2030 | $2.7368 | $3.1918 | $4.0162 | -52.15% |
| May, 2030 | $2.5811 | $2.6711 | $2.6855 | -54.88% |
| June, 2030 | $3.0786 | $3.338 | $3.2649 | -46.18% |
| July, 2030 | $2.4879 | $2.8079 | $2.8405 | -56.50% |
| August, 2030 | $2.2154 | $2.3454 | $2.4117 | -61.27% |
| September, 2030 | $3.3968 | $2.4273 | $2.8829 | -40.62% |
| October, 2030 | $2.6222 | $2.7322 | $2.8635 | -54.16% |
| November, 2030 | $2.9297 | $2.7435 | $2.7097 | -48.78% |
| December, 2030 | $3.0172 | $2.7853 | $2.7416 | -47.25% |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):